The controversy over Sirtris drugs reached a tipping point in January with a publication by Pfizer researchers led by Kay Ahn showing that resveratrol activates SIRT1 only when linked to a ...
GlaxoSmithKline PLC (GSK), of London, announced on April 22 that it would acquire Sirtris Pharmaceuticals of Cambridge, Massachusetts, for $720 million, making the month one of the busiest for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback